SH
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF · OTC
$0.47 +0.00% (+$0.00)
Market Cap ¥4.61B
P/E Ratio 22.73x
Div. Yield 4.51%
ROE 1.67%
Bulios Fair Price
$0.63
34.2% upside
Current Price
$0.47
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SHEZF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
78 /100
Cheap P/E 22.73x
P/B 0.39x
EV/EBITDA 11.90x
Growth
3 /100
Declining EPS growth 21.70%
Book val. growth 0.76%
Rev. growth 8.53%
Profitability
53 /100
Moderate Gross margin 33.33%
FCF margin 26.70%
Net margin 3.87%
Quality
8 /100
Poor ROIC 1.14%
Asset turnover 0.32x
ROE 1.67%
Debt
76 /100
Low Debt/Equity 0.24x
Net debt/EBITDA 2.73x
Current ratio 2.31x
Stability
35 /100
Moderate Beta 0.31x
Profitable years 2
Rev. volatility 14.43%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SHEZF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Li Li
Employees
1,926
Headquarters
Shenzhen